Rakovina Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Rakovina Therapeutics's estimated annual revenue is currently $603k per year.
- Rakovina Therapeutics's estimated revenue per employee is $100,500
Employee Data
- Rakovina Therapeutics has 6 Employees.
- Rakovina Therapeutics grew their employee count by -14% last year.
Rakovina Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Financial Officer | Reveal Email/Phone |
2 | COO | Reveal Email/Phone |
3 | President and CSO | Reveal Email/Phone |
Rakovina Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $33.4M | 166 | -10% | N/A | N/A |
#2 | $68.8M | 274 | 18% | $942.6M | N/A |
#3 | $23.5M | 117 | 0% | N/A | N/A |
#4 | $1.6M | 16 | 45% | $3.7M | N/A |
#5 | $0.7M | 7 | 0% | N/A | N/A |
#6 | $1.5M | 15 | 15% | N/A | N/A |
#7 | $1.4M | 14 | 17% | N/A | N/A |
#8 | $0.7M | 7 | -12% | N/A | N/A |
#9 | $17.7M | 88 | 24% | N/A | N/A |
#10 | $4.6M | 23 | -56% | N/A | N/A |
What Is Rakovina Therapeutics?
Rakovina Therapeutics’ focus is the development of new cancer treatments based on novel DNA-damage response technologies. The Company has established a pipeline of novel DNA-damage response inhibitors with the goal of advancing one or more drug candidates into human clinical trials and obtaining marketing approval for new cancer therapeutics from Health Canada, the United States Food and Drug Administration and similar international regulatory agencies.
keywords:N/A
N/A
Total Funding
6
Number of Employees
$603k
Revenue (est)
-14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Vancouver
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.4M | 6 | N/A | N/A |
#2 | $0.4M | 6 | N/A | N/A |
#3 | $0.4M | 6 | N/A | N/A |
#4 | $0.4M | 6 | N/A | N/A |
#5 | $0.6M | 6 | N/A | N/A |